Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and
Cesare Russo1, Zhezhen Jin, Shunichi Homma
1Department of Medicine, Columbia University, New York, NY 10032, USA.
Insights
Global longitudinal strain (GLS) detects subclinical brain disease, including silent brain infarcts, in the general population. This cardiac measure offers insights into cerebrovascular risk beyond traditional left ventricular ejection fraction (LVEF) assessment.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Subclinical cerebrovascular lesions like silent brain infarcts (SBIs) and white matter hyperintensities are linked to stroke and cognitive decline.
- Left ventricular ejection fraction (LVEF) predicts stroke in heart failure but its relation to subclinical brain disease in the general population is unclear.
- Left ventricular global longitudinal strain (GLS) can identify early cardiac dysfunction, even with normal LVEF.
Purpose of the Study:
- To investigate the association between LVEF, GLS, and subclinical brain disease in a community-based cohort.
- To determine if GLS provides additional information on cerebrovascular risk compared to LVEF.
Main Methods:
- Echocardiography (2D and speckle-tracking) assessed LVEF and GLS in 439 participants without prior stroke or cardiac disease.
- Brain MRI evaluated for SBIs and white matter hyperintensities.
- Multivariate analysis examined the relationship between cardiac measures and brain lesions.
Main Results:
- Lower GLS, but not LVEF, was significantly associated with the presence of SBIs.
- Reduced GLS independently predicted SBIs (OR 1.18 per unit decrease, P<0.01).
- Lower GLS correlated with greater white matter hyperintensity volume, while LVEF did not.
Conclusions:
- Lower GLS is independently associated with subclinical brain disease in a general community cohort.
- GLS offers valuable information regarding cerebrovascular risk beyond LVEF.
- GLS may serve as a novel biomarker for identifying individuals at risk for cerebrovascular events.
Background:
Silent brain infarcts (SBIs) and white matter hyperintensities are subclinical cerebrovascular lesions associated with incident stroke and cognitive decline. Left ventricular ejection fraction (LVEF) is a predictor of stroke in patients with heart failure, but its association with subclinical brain disease in the general population is unknown. Left ventricular global longitudinal strain (GLS) can detect subclinical cardiac dysfunction even when LVEF is normal. We investigated the relationship of LVEF and GLS with subclinical brain disease in a community-based cohort.
Methods And Results:
LVEF and GLS were assessed by 2-dimensional and speckle-tracking echocardiography in 439 participants free of stroke and cardiac disease from the Cardiovascular Abnormalities and Brain Lesions (CABL) study. SBIs and white matter hyperintensities were assessed by brain MRI. Mean age of the study population was 69±10 years, 61% were women, LVEF was 63.8±6.4%, GLS was -17.1±3.0%. SBIs were detected in 53 participants (12%), white matter hyperintensity volume was 0.63±0.86%. GLS was significantly lower in participants with SBI versus those without (-15.7±3.5% versus -17.3±2.9%, P<0.01), whereas no difference in LVEF was observed (63.3±8.6% versus 63.8±6.0%, P=0.60). In multivariate analysis, lower GLS was associated with SBI (odds ratio/unit decrease=1.18; 95% confidence interval, 1.05-1.33; P<0.01), whereas LVEF was not (odds ratio/unit increase=1.00; 95% confidence interval, 0.96-1.05; P=0.98). Lower GLS was associated with greater white matter hyperintensity volume (adjusted β=0.11, P<0.05), unlike LVEF (adjusted β=-0.04, P=0.42).
Conclusions:
Lower GLS was independently associated with subclinical brain disease in a community-based cohort without overt cardiac disease. GLS can provide additional information on cerebrovascular risk burden beyond LVEF assessment.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology


